Evolution of health care utilization and expenditure during the year before death in 2015 among people with cancer: French snds-based cohort study

Audrey Tanguy-Melac, Dorian Verboux, Laurence Pestel, Anne Fagot-Campagna, Philippe Tuppin and Christelle Gastaldi-Ménager
Additional contact information
Audrey Tanguy-Melac: Caisse Nationale de l’Assurance Maladie (Cnam)
Laurence Pestel: Caisse Nationale de l’Assurance Maladie (Cnam)
Anne Fagot-Campagna: Caisse Nationale de l’Assurance Maladie (Cnam)
Philippe Tuppin: Caisse Nationale de l’Assurance Maladie (Cnam)
Christelle Gastaldi-Ménager: Caisse Nationale de l’Assurance Maladie (Cnam)

The European Journal of Health Economics, 2021, vol. 22, issue 7, No 5, 1039-1052

Abstract: Abstract Background Cancer patients have one of the highest health care expenditures (HCE) at the end of life. However, the growth of HCE at the end of life remains poorly documented in the literature. Objective To describe monthly reimbursed expenditure during the last year of life among cancer patients, by performing detailed analysis according to type of expenditure and the person’s age. Method Data were derived from the Système national des données en santé (SNDS) [national health data system], which comprises information on ambulatory and hospital care. Analyses focused on general scheme beneficiaries (77% of the French population) treated for cancer who died in 2015. Results Average reimbursed expenditure during the last year of life was €34,300 per person in 2015, including €21,100 (62%) for hospital expenditure. "Short-stays hospital" and "rehabilitation units" stays expenditure were €14,700 and €2000, respectively. Monthly expenditure increased regularly towards the end of life, increasing from 12 months before death €2000 to €5200 1 month before death. The highest levels of expenditure did not concern the oldest people, as average reimbursed expenditure was €50,300 for people 18–59 years versus €25,600 for people 80–90 years. Out-of-pocket payments varied only slightly according to age, but increased towards the end of life. Conclusion A marked growth of HCE was observed during the last 4 months of life, mainly driven by hospital expenditure, with a more marked growth for younger people.

Keywords: End-of-life; Cancer; Healthcare expenditure; France; Out-of-pocket; Administrative database (search for similar items in EconPapers)
JEL-codes: I10 I14 I18 (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s10198-021-01304-1 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:eujhec:v:22:y:2021:i:7:d:10.1007_s10198-021-01304-1

Ordering information: This journal article can be ordered from
http://www.springer. ... cs/journal/10198/PS2

DOI: 10.1007/s10198-021-01304-1

Access Statistics for this article

The European Journal of Health Economics is currently edited by J.-M.G.v.d. Schulenburg

More articles in The European Journal of Health Economics from Springer, Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ) Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().